The H1047R point mutation in p110 alpha of PI3K decrease Bcl2 expression in human colon cancer HCT116 cells

被引：0
|
作者：
Wan, Guanghua [1 ]
Rajput, Ashwani [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5008
引用
收藏
页数：2
相关论文
共 43 条
  • [1] The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
    G Wan
    C Pehlke
    R Pepermans
    JL Cannon
    D Lidke
    A Rajput
    [J]. Cell Death Discovery, 1
  • [2] The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
    Wan, G.
    Pehlke, C.
    Pepermans, R.
    Cannon, J. L.
    Lidke, D.
    Rajput, A.
    [J]. CELL DEATH DISCOVERY, 2015, 1
  • [3] The Hi 047R point mutation in p110 alpha of PI3K down-regulates INPP4B expression in human colon cancer HCT116 cells
    Wan, Guanghua
    Ness, Scott A.
    Rajput, Ashwani
    [J]. CANCER RESEARCH, 2016, 76
  • [4] Motility of human colorectal cancer cells is promoted by H1047R kinase mutation of PI3K p110-alpha
    Wan, Guanghua
    Ongchin, Melanie
    Hand, Essence
    Rajput, Ashwani
    [J]. CANCER RESEARCH, 2012, 72
  • [5] Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K
    Yueh, Alexander E.
    Payne, Susan N.
    Leystra, Alyssa A.
    Van De Hey, Dana R.
    Foley, Tyler M.
    Pasch, Cheri A.
    Clipson, Linda
    Matkowskyj, Kristina A.
    Deming, Dustin A.
    [J]. PLOS ONE, 2016, 11 (02):
  • [6] H1047R mutation of p110 alpha alters expression level of genes which are associated with cell migration & cancer metastasis
    Wan, Guanghua
    Kang, Huining
    Ness, Scott
    Greenbam, Alissa
    Rajput, Ashwani
    [J]. CANCER RESEARCH, 2017, 77
  • [7] DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)
    Liu, Jia-li
    Gao, Guo-rui
    Zhang, Xi
    Cao, Su-fen
    Guo, Chen-liang
    Wang, Xiang
    Tong, Lin-jiang
    Ding, Jian
    Duan, Wen-hu
    Meng, Ling-hua
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (03): : 432 - 441
  • [8] Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo
    Hanker, Ariella B.
    Kuba, Maria G.
    Sanchez, Violeta
    Sutton, Cammie R.
    Pfefferle, Adam
    Balko, Justin M.
    Perou, Charles M.
    Cook, Rebecca S.
    Arteaga, Carlos L.
    [J]. CANCER RESEARCH, 2012, 72
  • [9] Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer
    Simond, Alexandra M.
    Bui, Tung
    Zuo, Dongmei
    Sanguin-Gendreau, Virginie
    Rao, Trisha
    Phillips, Wayne A.
    Cardiff, Robert D.
    Muller, William J.
    [J]. ONCOGENE, 2022, 41 (25) : 3445 - 3451
  • [10] Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer
    Alexandra M. Simond
    Tung Bui
    Dongmei Zuo
    Virginie Sanguin-Gendreau
    Trisha Rao
    Wayne A. Phillips
    Robert D. Cardiff
    William J. Muller
    [J]. Oncogene, 2022, 41 : 3445 - 3451
12345